...
机译:Ustekinumab牛皮癣患者抗体形成,血清浓度和HLA-CW6状态的临床后果
Ghent Univ Hosp Dept Dermatol Ghent Belgium;
Univ Amsterdam Amsterdam UMC Dept Dermatol Amsterdam Netherlands;
Ghent Univ Hosp Dept Dermatol Ghent Belgium;
Private Dermatol Practice Lede Belgium;
Univ Amsterdam Acad Med Ctr Dept Clin Epidemiol Amsterdam Netherlands;
Sapienza Univ Dept Dermatol Rome Italy;
Radboud Univ Nijmegen Nijmegen Med Ctr Dept Dermatol Nijmegen Netherlands;
Radboud Univ Nijmegen Nijmegen Med Ctr Dept Dermatol Nijmegen Netherlands;
Ghent Univ Hosp Dept Dermatol Ghent Belgium;
Univ Amsterdam Amsterdam UMC Dept Dermatol Amsterdam Netherlands;
psoriasis; immunogenicity; drug monitoring; ustekinumab;
机译:Ustekinumab牛皮癣患者抗体形成,血清浓度和HLA-CW6状态的临床后果
机译:在临床实践中乌斯替单抗治疗的牛皮癣患者的临床疗效,血清谷水平和抗药物抗体的相关性
机译:在临床实践中,使用ustekinumab治疗的牛皮癣患者的临床疗效,血清谷水平和抗药物抗体的相关性
机译:健康状况的客观评价:哈达氟胺血清浓度作为整理猪临床症状的标志物
机译:犬血清中3-溴酪氨酸浓度的测定方法及其临床应用
机译:Ustekinumab牛皮癣患者抗体形成血清浓度和HLA-Cw6状态的临床后果
机译:抗体形成,血清浓度和HLA-CW6地位在牛皮癣患者中的临床后果Ustekuinubab